| 11 Dec 2025 | 11:30:53 | Disposal of Subsidiary: The GP Service Limited |
| 28 Nov 2025 | 16:02:18 | Appointment of Joint Administrators |
| 1 May 2025 | 07:30:00 | Suspension - Kanabo Group plc |
| 30 Apr 2025 | 14:47:11 | Temporary suspension of listing |
| 4 Apr 2025 | 16:20:34 | Business Update |
| 21 Jul 2025 | Annual Report and Accounts (to 2023-12-31) | |
| 11 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 1 Jan 2024 | Annual Report & Financial Statements 2023 |
Kanabo Group plc is a digital health company focused on transforming patient care through its technology platform and specialized treatment offerings. It develops and commercializes regulated medicinal cannabis-derived formulations and therapeutic inhalation devices. Kanabo operates two main divisions: Digital Health Services, which includes an NHS-approved telehealth platform for consultations and prescriptions, and Specialised Medicines, which encompasses its medicinal cannabis products. The company serves patients in the UK, providing access to medical cannabis treatments and chronic pain management through its online clinic, Treat-It, and an expanding network of in-pharmacy clinics.
| 11 Dec 2025 | 11:30:53 | Disposal of Subsidiary: The GP Service Limited |
| 28 Nov 2025 | 16:02:18 | Appointment of Joint Administrators |
| 1 May 2025 | 07:30:00 | Suspension - Kanabo Group plc |
| 30 Apr 2025 | 14:47:11 | Temporary suspension of listing |
| 4 Apr 2025 | 16:20:34 | Business Update |
| 21 Jul 2025 | Annual Report and Accounts (to 2023-12-31) | |
| 11 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 1 Jan 2024 | Annual Report & Financial Statements 2023 |
Kanabo Group plc is a digital health company focused on transforming patient care through its technology platform and specialized treatment offerings. It develops and commercializes regulated medicinal cannabis-derived formulations and therapeutic inhalation devices. Kanabo operates two main divisions: Digital Health Services, which includes an NHS-approved telehealth platform for consultations and prescriptions, and Specialised Medicines, which encompasses its medicinal cannabis products. The company serves patients in the UK, providing access to medical cannabis treatments and chronic pain management through its online clinic, Treat-It, and an expanding network of in-pharmacy clinics.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £939m | +0.0% | |
| £449m | -0.4% | |
| £306m | -0.1% | |
| £205m | +0.1% | |
| £84m | +0.1% | |
KNBKanabo Group PLC | — | — |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £939m | +0.0% | |
| £449m | -0.4% | |
| £306m | -0.1% | |
| £205m | +0.1% | |
| £84m | +0.1% | |
KNBKanabo Group PLC | — | — |
